LYNN WOJTYSIAK: Open Payments
NPI 1992775670 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 70 payments from 15 companies in 2025. Trend: 2023 $1,551 · 2024 $1,823 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 6 | $337 |
| E.R. Squibb & Sons, L.L.C. | 27 | $228 |
| PFIZER INC. | 15 | $161 |
| AstraZeneca Pharmaceuticals LP | 6 | $123 |
| Boston Scientific Corporation | 2 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
Products named: Assure WCD, ELIQUIS, CAMZYOS, FARXIGA, VYNDAQEL, WATCHMAN FLX, JARDIANCE, LEQVIO.
Industry payments across MD — which companies pay providers there.
